AC Immune to Present at the Jefferies 2023 London Healthcare Conference
07 nov. 2023 07h00 HE
|
AC Immune SA
AC Immune to Present at the Jefferies 2023 London Healthcare Conference Lausanne, Switzerland, November 7, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering...
Gevo CFO Lynn Smull to Participate in a Water Tower Research Fireside Chat on Thursday, October 12th at 4:00 pm ET
10 oct. 2023 09h00 HE
|
Gevo, Inc.
ENGLEWOOD, Colo., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), announced today that Lynn Smull, Chief Financial Officer, will participate in a Water Tower Research Fireside Chat on...
Arcutis to Present at Upcoming Investor Conference
05 sept. 2023 16h00 HE
|
Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early-stage commercial company focused on developing meaningful innovations in...
Dr. Patrick Gruber to Participate in a Water Tower Research Fireside Chat on Thursday, August 17th at 4:00 pm ET
15 août 2023 16h01 HE
|
Gevo, Inc.
ENGLEWOOD, Colo., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), announced today that Dr. Patrick Gruber, Chief Executive Officer, will participate in a Water Tower Research Fireside...
AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023
28 juil. 2023 07h00 HE
|
AC Immune SA
AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023 Lausanne, Switzerland, July 28, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering...
Patrick Gruber to Participate in a Water Tower Research Fireside Chat on Tuesday, June 13th at 4:00 pm ET
08 juin 2023 16h23 HE
|
Gevo, Inc.
ENGLEWOOD, Colo., June 08, 2023 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), announced today that Patrick Gruber, Chief Executive Officer, will participate in a Water Tower Research Fireside Chat...
Arcutis to Present at Upcoming Investor Conference
06 juin 2023 16h00 HE
|
Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early-stage commercial company focused on developing meaningful innovations in...
Arbutus to Present at Jefferies Healthcare Conference
31 mai 2023 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., May 31, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
H&R Block to Participate in the Oppenheimer 23rd Annual Consumer Growth & E-Commerce Conference
30 mai 2023 16h35 HE
|
HRB Tax Group, Inc.
KANSAS CITY, Mo., May 30, 2023 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) (the “Company”) today announced that Jeff Jones, President and Chief Executive Officer, and Tony Bowen, Chief...
Arbutus to Present at JMP Securities Life Sciences Conference
09 mai 2023 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...